Lunatocapitate Fusion Versus Four-corner Fusion for SNAC and SLAC Arthritis.
Sponsored by Karolinska Institutet
About this trial
Last updated 2 years ago
Study ID
MIKA1
Status
Active, not recruiting
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Started 8 years ago
What is this trial about?
Hypothesis: Lunate-capitate-fusion (LCF) results in comparable outcome (i.e. not worse) to
four-corner-fusion (4CF) for Scaphoid Nonunion Advanced Collapse (SNAC) and Scapholunate
Advanced Collapse (SLAC) arthritis regarding functional results (grip strength).
Design: Prospective randomised comparison. Inclusion criteria: SNAC or SLAC arthritis
requiring a salvage procedure (grade 2-3).
Exclusion criteria: SNAC or SLAC arthritis grade 4 (panarthritis). Inability to co-operate
with the follow-up protocol (language difficulties, severe psychiatric disorder or drug
addiction).
What are the participation requirements?
Inclusion Criteria
- SNAC or SLAC arthritis grade 2-3
Exclusion Criteria
- SNAC or SLAC arthritis grade 4
- Inability to cooperate with the follow-up protocol